Search

Search Constraints

You searched for: Author/Creator Caux, F.

Search Results

11. International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita. (8th May 2018)

12. International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg−1 per day starting dose of oral corticosteroids to treat bullous pemphigoid. (1st December 2021)

13. International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg−1 per day starting dose of oral corticosteroids to treat bullous pemphigoid. (2nd September 2021)

15. Oesophageal involvement in 26 consecutive patients with mucous membrane pemphigoid. (1st October 2017)

16. Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid. (30th January 2013)

19. Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris. (27th June 2022)

20. Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study. (15th June 2021)